The development of cancer drugs which harness the power of the patient’s immune system has altered the paradigm of cancer care in the past few years. The development of these drugs require complex cellular models and assays for lead identification and characterization. A key parameter for the development of these cancer drugs is to use phenotyping and functional assays to assess and characterize immune cells.
Technologies that can robustly and reliably provide high content immunophenotypic and functional data are critical for the rapid development of these new drugs.
Download the infographic by completing the form below, to find out more about: